Our AMA will urge public and private payers who use prior authorization programs for prescription drugs to minimize administrative burdens on prescribing physicians.

Policy Timeline

Sub. Res. 529, A-05Reaffirmation A-06Reaffirmation A-08Reaffirmed in lieu of Res. 822, I-11Reaffirmed: CMS Rep. 1, A-21Reaffirmation: A-22